| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10212897 | The Annals of Thoracic Surgery | 2018 | 6 Pages |
Abstract
Positive staining for PD-L1 may be a prognostic marker for decreased survival in esophageal adenocarcinoma. Additional TIL cell types should be investigated for creation of an esophageal cancer Immunoscore. PD-L1 has potential as a therapeutic target.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Conor F. MD, Dong H. MD, Chaitanya MD, Alexander MD, Aya MS, Joeffrey J. MS, Sameer MS, Marc MD, Bhaskar V. MD, Thomas J. MD, Nadim G. MD, M. Blair MD,